Form D — Unravel Biosciences, Inc.

0001876967-26-000002 · filed Aug 24, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $4,500,000
Reported amount sold: $4,100,000
Minimum investment: $0
Investors: 2
Sales commission: $0
Finders' fees: $0

Issuer

Name: Unravel Biosciences, Inc.
CIK: 1876967
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 196 BOSTON AVE., SUITE 1000
MEDFORD, MA 02155
Phone: 510-984-2317

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Richard Novak · Executive Officer

Medford, MA Find on LinkedIn ↗
Frederic Vigneault · Director

Medford, MA Find on LinkedIn ↗
Donald Ingber · Director

Medford, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗